Search results
Your search for TFRC returned no results
Showing 2351 to 2400 of 2490 results for term
Showing 2351 to 2400 of 2490 results for term
A timeline showing where in the NICE evaluation process companies will be charged.
International collaboration with NICE
The standing committees were responsible for the development of our public health guidance.
A clear focus on Chronic Obstructive Pulmonary Disease (COPD) driving up uptake of Covid, Flu and Pneumonia vaccines to reduce infective exacerbations and emergency hospital admissions due to those exacerbations.
People coming off obesity medication or finishing a weight management programme should be offered support to help keep the weight off and stay healthy long-term, according to our updated quality standard.
"itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/","name":"Home"}}]} Terms and conditions The NICE websites ("the...
Embed NICE content in your digital products and services with our syndication API.
Permission to use NICE content for artificial intelligence (AI) purposes
Permission form to use NICE content for artificial intelligence (AI) purposes.
Evidence standards framework (ESF) for digital health technologies
NICE standards for innovators of digital health technologies and NHS commissioners
Hundreds with rare inherited eye disease to benefit after NICE recommends treatment
NICE recommends idebenone for Leber's hereditary optic neuropathy following clinical evidence of vision improvement.
justice system (quality standard QS163) Violence and aggression: short-term management in mental health, health and community settings...
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.
under the terms of the NICE knowledge resources framework agreement (NICEFAHEE/2528) who the users will be any specific requirements or...
NICE's equality, diversity, and inclusion roadmap and annual action plan - committed to creating a forward-looking, positive work culture where everyone can thrive.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Agenda and papers of the NICE public board meeting on 25 May 2022
Agenda and papers of the NICE public board meeting on 20 May 2025
Agenda and papers of the NICE public board meeting on 17 May 2023
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
Agenda and papers of the NICE public board meeting on 15 May 2024
Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country
Agenda and papers of the NICE public board meeting on 11 December 2024
Agenda and papers of the NICE public board meeting on 21 September 2023
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation.
Read NICE's statement on modern slavery and human trafficking.
Thousands could benefit from first immunotherapy for severe birch tree pollen allergy
We have recommended the first under-the-tongue tablet immunotherapy shown to build long-term tolerance to allergens, which could help up to 27,000 people in England with moderate to severe birch tree pollen allergies.
NICE's past research and projects
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
The Marmot Review concluded that being in good employment is usually protective of health while unemployment, particularly long term unemployment, contributes significantly to poor health.
The wider determinants of health are a broad range of social, economic and environmental factors that influence people’s health and well-being.
In the Labonte model, physiological impacts refer to the direct effects on the body’s systems and functions due to factors such as stress, lifestyle choices, and environmental conditions.
The Marmot Review summarised the importance the impact of addressing inequalities in health in later life and investing in the early years to preventing ill health later in life.
The Marmot review set out to identify effective evidence-based strategies for reducing health inequalities.
Create and develop healthy and sustainable places and communities
The Marmot Review assessed the importance of communities in shaping physical and mental health and wellbeing and described how inequalities among communities are related to inequalities in health.
The Labonte model identifies psycho-social factors as crucial determinants of health.
Read NICE's patient and public involvement policy.
Our board has 2 sub-committees: the audit and risk assurance committee and the remuneration committee.
receiving social care in the community guideline Older people and multiple long-term conditions guideline People's experience in adult...
this upsets her. Action Alice's social worker uses guidance on the short-term management of violence and aggression in mental health,...
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
The innovative hybrid closed loop (HCL) systems offer improved blood sugar control and can transform daily life for families managing this complex condition.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
period of agreement 2.1 This Agreement fully incorporates and expands the terms of a previous agreement (dated 11 November 2019)...
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
NICE leads the way in approving breakthrough treatment for multiple myeloma
People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year.
In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.
We’re bringing our guidance together by topic, so that it’s all in one place, clearer to understand and easier to use.